Your process validations are inadequate.
Inspection Record
MicroBioPharm Japan Co., Ltd — FDA 483 Findings
Inspectors Tamil ArasuThe inspectors who signed the published document.Inspector lookup
View the regulator's official source The source document is always the basis for judgement.
Findings
Your firm failed to establish adequate written procedures for cleaning and maintenance of equipment used in the manufacture, processing, or holding of drug substances, and failed to validate cleaning procedures to ensure that equipment is routinely cleaned to prevent contamination.
Your firm failed to establish and follow appropriate written procedures for equipment qualification.
A record as of the US FDA document published on 2026-11-05. Check the agency's announcements for any later corrective action, and rely on the original text. Translation and classification are machine-made.